RASSF1F inhibitors are a class of chemical compounds that specifically target and inhibit the function of RASSF1F, one of the spliced isoforms of the Ras Association Domain Family 1 (RASSF1) gene. The RASSF1 gene is part of a family of proteins known for their involvement in crucial cellular processes such as apoptosis, cell cycle regulation, and cytoskeletal dynamics. RASSF1 isoforms, including RASSF1F, typically interact with the Ras family of GTPases and other key signaling molecules to modulate pathways that control cell growth and programmed cell death. Each isoform, including RASSF1F, can have distinct roles within these regulatory pathways. Inhibitors of RASSF1F function by disrupting its ability to interact with other proteins, such as scaffolding proteins or kinases, which are essential for its role in mediating cellular signaling events.
The inhibition of RASSF1F affects pathways related to cell cycle control, apoptosis, and cytoskeletal integrity, as RASSF1F is believed to play a unique role in these processes compared to other RASSF1 isoforms. By blocking its interactions with signaling molecules, RASSF1F inhibitors prevent the proper regulation of cellular responses to stress, growth signals, or cell death cues. Researchers use RASSF1F inhibitors to explore the specific contribution of this isoform to the broader RASSF1 family's regulatory functions, allowing for a better understanding of how alternative splicing of RASSF1 results in functional diversity. Additionally, these inhibitors provide insights into the complex regulatory networks involving Ras and Ras-associated proteins, highlighting how the fine-tuning of signaling pathways governs key cellular outcomes. By studying RASSF1F inhibitors, scientists can better understand how this isoform influences critical cellular functions, such as maintaining homeostasis, regulating cell death, and shaping the cytoskeleton, which are vital for normal cellular operation and response to environmental stimuli.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
This agent may directly downregulate RASSF1F by inhibiting DNA methyltransferase, leading to hypomethylation and transcriptional activation of gene regions typically silenced in cancer cells. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
Suberoylanilide Hydroxamic Acid could decrease RASSF1F promoter methylation through histone deacetylase inhibition, resulting in increased histone acetylation and potentially less suppression of the gene expression. | ||||||
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $218.00 $322.00 $426.00 | 7 | |
By specifically targeting DNA methyltransferases, 5-Aza-2′-Deoxycytidine may decrease methylation levels at the RASSF1F promoter, which could lead to reactivation of its expression in silenced cells. | ||||||
RG 108 | 48208-26-0 | sc-204235 sc-204235A | 10 mg 50 mg | $131.00 $515.00 | 2 | |
RG 108 may directly target and inhibit DNA methyltransferases, which in turn could result in the hypomethylation and subsequent re-expression of the downregulated RASSF1F gene. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
Genistein, through its potential inhibition of DNA methyltransferases, could decrease hypermethylation of the RASSF1F promoter, which is a common mechanism of gene silencing. | ||||||
D,L-Sulforaphane | 4478-93-7 | sc-207495A sc-207495B sc-207495C sc-207495 sc-207495E sc-207495D | 5 mg 10 mg 25 mg 1 g 10 g 250 mg | $153.00 $292.00 $489.00 $1325.00 $8465.00 $933.00 | 22 | |
DL-Sulforaphane may promote histone acetylation by inhibiting histone deacetylases, potentially reducing the repression of transcription and allowing for the increased expression of RASSF1F. | ||||||
Disulfiram | 97-77-8 | sc-205654 sc-205654A | 50 g 100 g | $53.00 $89.00 | 7 | |
Disulfiram could indirectly lead to an accumulation of acetyltransferases, which might decrease the repressive chromatin structure at the RASSF1F locus, promoting its expression. | ||||||
Mithramycin A | 18378-89-7 | sc-200909 | 1 mg | $55.00 | 6 | |
By binding to specific DNA sequences, Mithramycin A may prevent the binding of transcriptional repressors to the RASSF1F promoter, decreasing the suppression of this gene. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Curcumin may downregulate the expression of DNMTs and HDACs, which are responsible for the silencing of tumor suppressor genes like RASSF1F, thus potentially increasing its expression. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Resveratrol may lead to the downregulation of specific signaling pathways involved in cell growth that, when inhibited, could lead to reduced suppression of RASSF1F expression. | ||||||